Affiliation:
1. National Institute of Cholera and Enteric Diseases (ICMR), Beliaghata, Calcutta, India.
Abstract
In a double-blind, randomized clinical trial with 78 adults with acute watery diarrhea and severe dehydration, 37 subjects were positive for Vibrio cholerae. In conjunction with rehydration therapy, 13 patients received norfloxacin, 12 received trimethoprim-sulfamethoxazole (TMP-SMX), and 12 received a placebo. Norfloxacin was superior to TMP-SMX and to the placebo in reducing stool output, duration of diarrhea, fluid requirements, and vibrio excretion. TMP-SMX was no better than the placebo.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference11 articles.
1. Antibiotic susceptibility testing by a standarized single disc method;Bauer A. W.;Am. J. Chin. Pathol.,1966
2. Clinical studies in Asiatic cholera. IV. Antibiotic therapy in cholera;Carpenter C. C. J.;Bull. Johns Hopkins Hosp.,1966
3. Effect of chemotherapy on the duration of diarrhoea and on vibrio excretion by cholera patients;Francis T.;J. Trop. Med. Hyg.,1971
4. In vitro susceptibility of pathogenic Vibrio species to norfloxacin and six other antimicrobial agents;Morris J. G.;Antimicrob. Agents Chemother.,1985
5. Controlled comparison of tetracycline and furazolidone in cholera;Pierce N. F.;Br. Med. J.,1968
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献